Two Sigma Securities’s Yield10 Bioscience YTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-681
Closed -$6.21K – 3864
2024
Q1
$6.21K Buy
+681
New +$4.28K ﹤0.01% 2816
2023
Q4
– Sell
-509
Closed -$3.99K – 3755
2023
Q3
$3.99K Buy
+509
New +$12.8K ﹤0.01% 2803
2019
Q1
– Sell
-13
Closed -$10K – 2563
2018
Q4
$10K Buy
13
+2
+18% +$2.44K ﹤0.01% 2019
2018
Q3
$15K Buy
+11
New +$14.9K ﹤0.01% 2475

Two Sigma Securities's YTEN Position: Q2 2024 in Review

Two Sigma Securities sold out of Yield10 Bioscience (YTEN) in Q2 2024, closing a stake of 681 shares — an estimated $6.21K sold.

Two Sigma Securities first reported a position in YTEN in Q3 2018 and held it in 4 quarters. The position peaked at $15K in Q3 2018. 0 funds tracked by Wall St. Rank hold YTEN as of Q2 2024.

  • Two Sigma Securities reported no remaining Yield10 Bioscience position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Securities sold 681 Yield10 Bioscience shares in Q2 2024, an estimated $6.21K.
  • Two Sigma Securities first reported a position in Yield10 Bioscience in Q3 2018 and held it in 4 quarters.
  • Two Sigma Securities's Yield10 Bioscience position peaked at $15K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Yield10 Bioscience as of Q2 2024.

Based on Two Sigma Securities's 13F filing for Q2 2024, filed 14 Aug 2024.